Oscar Health price target raised to $20 from $12 at Wells Fargo

Wells Fargo raised the firm’s price target on Oscar Health to $20 from $12 and keeps an Overweight rating on the shares. The firm is “increasingly confident” in Oscar Health’s financial trajectory and the ability to grow membership while improving margins. Nonetheless, Wells acknowledges the bar for “what you need to believe from here” is clearly higher.